• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library
    Biotech

    Aligos Therapeutics To Release 1Q 2026 Financial Results On May 7

    GLOBENEWSWIRE

    Aligos Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    GLOBENEWSWIRE

    Aligos Reveals Phase 2 B-SUPREME Study Interim Data

    GLOBENEWSWIRE

    Aligos Therapeutics Updates Business Progress And 2025 Financials

    GLOBENEWSWIRE

    Aligos Therapeutics Reveals Positive Data At (CROI) Conference

    GLOBENEWSWIRE

    Aligos Provides Phase 2 B-SUPREME Study Progress Updates

    GLOBENEWSWIRE

    Aligos Therapeutics Presents Positive Data At HEP-DART 2025

    GLOBENEWSWIRE

    Aligos Therapeutics Presents Positive Data at Liver Meeting

    GLOBENEWSWIRE

    Aligos Therapeutics Updates Business Progress & Q3 2025

    GLOBENEWSWIRE

    Aligos Therapeutics to Release Q3 2025 Financial Results on Nov

    GLOBENEWSWIRE

    Aligos Therapeutics Gets USAN Approval For Pevifoscorvir Sodium

    GLOBENEWSWIRE

    Aligos Launches Ph2 Study in Chronic Hepatitis B Patients

    GLOBENEWSWIRE

    Aligos Therapeutics Reports Q2 2025 Financials and Business

    GLOBENEWSWIRE

    Aligos Therapeutics to Reveal Q2 2025 Financial Results on Aug 6

    GLOBENEWSWIRE

    Aligos Therapeutics Reports Business Progress and Q1 2025 Results

    GLOBENEWSWIRE

    Aligos Therapeutics to Announce Q1 2025 Results on May 6, 2025

    GLOBENEWSWIRE

    Aligos Therapeutics Presents Positive Data at APASL 2025

    GLOBENEWSWIRE

    Aligos Reports Q4, Full-Year 2024 Financials, Business Progress

    GLOBENEWSWIRE

    Aligos To Announce Q4 FY24 Results On March 10

    GLOBENEWSWIRE

    Aligos Therapeutics Announces $105 M Private Placement Financing

    GLOBENEWSWIRE

    Hepatitis B drug developers chart slow progress, just like hep C

    FIERCE BIOTECH

    Aligos culls another hep B asset over inconclusive efficacy data

    FIERCE BIOTECH

    Aligos Announces the Selection of Stephen Harrison as Principal Investigator of Ph2a Study for ALG-055009

    GLOBENEWSWIRE

    Aligos Presents Data from its Liver Disease Programs at the EA for (EASL)

    GLOBENEWSWIRE

    Aligos Therapeutics Collaborate with Xiamen Amoytop Biotech

    INVESTING

    Aligos Announces Strategic Reprioritization of NASH and COVID-19 Programs

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.